Fredun Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on March 31, 2016, has decided to presently cancel the matter of issuing the Equity shares of the Company to the Investors under the Preferential Guidelines. Further, the Board of Directors of the Company at their meeting held on March 31, 2016 has declared an Interim Dividend of 0.60 paise (6%) per share for the year ending March 31, 2016.
The above information is a part of company’s filings submitted to BSE.
